XBP1 and triple-negative breast carcinoma: Another, more complex example is to administrate the peptide vaccine PVX-410 (derived from X-box-binding protein 1-unspliced XBP1-US, XBP1-spliced syndecan-1, and CS1), to treat triple-negative breast cancer tumors (NCT02826434).